Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

This study has been completed.
Bristol-Myers Squibb
Hoffmann-La Roche
Information provided by (Responsible Party):
French National Agency for Research on AIDS and Viral Hepatitis Identifier:
First received: July 19, 2005
Last updated: December 21, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2007
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):